Stay updated on Rapastinel Long-term Safety in Major Depressive Disorder Clinical Trial
Sign up to get notified when there's something new on the Rapastinel Long-term Safety in Major Depressive Disorder Clinical Trial page.

Latest updates to the Rapastinel Long-term Safety in Major Depressive Disorder Clinical Trial page
- Check4 days agoChange DetectedA banner announces an NIH terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check10 days agoChange DetectedThe site revision label in the footer advances from v3.7.1 to v3.7.2 while the study record remains inaccessible behind a 403 error.SummaryDifference0.2%

- Check17 days agoChange DetectedThe revision identifier in the footer changed from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check31 days agoChange DetectedThe study record page now shows a 403 Forbidden message with a minimal header and a Home link, indicating restricted access rather than changes to the study details.SummaryDifference16%

- Check38 days agoChange DetectedThe page now displays Revision: v3.7.0, replacing the previous v3.6.6. This indicates a site-wide update rather than a modification to the study content.SummaryDifference0.0%

- Check52 days agoChange DetectedRevision: v3.6.6 appears, replacing v3.6.5; this denotes a page version update rather than substantive content changes to the study details.SummaryDifference0.0%

Stay in the know with updates to Rapastinel Long-term Safety in Major Depressive Disorder Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rapastinel Long-term Safety in Major Depressive Disorder Clinical Trial page.